Compare JZXN & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JZXN | BJDX |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.8M |
| IPO Year | 2020 | 2021 |
| Metric | JZXN | BJDX |
|---|---|---|
| Price | $1.18 | $2.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 39.8K |
| Earning Date | 02-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $249,040.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.63 |
| 52 Week High | $8.50 | $4.17 |
| Indicator | JZXN | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 64.15 |
| Support Level | $0.84 | $1.72 |
| Resistance Level | $1.89 | $3.85 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 26.46 | 88.43 |
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It is into trade business with a focus on sales of new energy batteries including design, commissioned processing, transportation and packaging, sales of electrical equipment, mobile phone accessories and other products. Its revenues consist of two reportable operating segments: (i) Sales of new energy batteries, including production, transportation, and packaging, in the mainland Pearl River Delta region; and(ii) Sales and production of electric vehicles in Southeast Asia, including two-wheelers, three-wheeled electric scooters, and slow-speed vehicles.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.